Analysts expect Novo Nordisk A S to report revenue of 11.37 B for Q3 26, against a range of 10.69 B to 12.05 B. The most recent reported quarter, Q2 26, came in at 12.13 B, a 5.6% beat against the 11.48 B consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 10.27 B | 11.97 B | 11.90 B | 11.97 B | 11.53 B | 12.50 B | 11.02 B | 12.13 B | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 11.84 B | 12.51 B | 11.81 B | 12.61 B | 11.92 B | 12.63 B | 12.20 B | 12.30 B | 12.05 B | 13.25 B | 12.55 B | 11.70 B | 12.17 B | 13.65 B | 12.21 B | 13.20 B | ||||||||||
| Low Estimate | 9.76 B | 10.50 B | 9.96 B | 10.70 B | 10.41 B | 10.76 B | 10.47 B | 10.67 B | 10.69 B | 10.89 B | 11.37 B | 10.75 B | 10.68 B | 11.97 B | 10.13 B | 12.19 B | ||||||||||
| Consensus Estimate | 10.80 B | 11.51 B | 10.88 B | 11.65 B | 11.16 B | 11.69 B | 11.33 B | 11.48 B | 11.37 B | 12.07 B | 11.96 B | 11.23 B | 11.42 B | 12.81 B | 11.17 B | 12.70 B |
Analysts expect Novo Nordisk A S to report earnings per share of 0.73 for Q3 26, against a range of 0.70 to 0.76. The most recent reported quarter, Q2 26, came in at 0.96, a 20.0% beat against the 0.80 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.88 | 0.89 | 0.99 | 0.93 | 0.69 | 0.95 | 1.04 | 0.96 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.92 | 0.87 | 0.99 | 1.00 | 0.84 | 1.01 | 1.00 | 0.88 | 0.76 | 0.68 | 1.10 | 0.84 | 0.82 | 0.88 | 1.01 | 1.02 | ||||||||||
| Low Estimate | 0.78 | 0.75 | 0.93 | 0.90 | 0.74 | 0.91 | 0.82 | 0.72 | 0.70 | 0.62 | 0.94 | 0.78 | 0.74 | 0.76 | 0.95 | 0.88 | ||||||||||
| Consensus Estimate | 0.85 | 0.81 | 0.96 | 0.95 | 0.79 | 0.96 | 0.91 | 0.80 | 0.73 | 0.65 | 1.02 | 0.81 | 0.78 | 0.82 | 0.98 | 0.95 |
Pull Wall Street consensus for Novo Nordisk A S (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=NVO&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "NVO", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=NVO&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();